<p>On this episode of Funded, Emilė Radytė, co-founder and CEO of Samphire Neuro, shares how she went from academic neuroscientist to building a regulated neurotechnology company for women's hormonal health — a category most investors didn't even recognize. She talks about raising with no VC network, why hardware and women's health made investors nervous, and the mindset shift that changed everything: counting the nos instead of waiting for the yes. We also hear from her lead investor Kevin at In Venture, who cold-messaged her on LinkedIn, found out the round was already closing, and flew to London the next day to fight his way in. It's a real look at what it takes to hold conviction in a market no one has mapped yet — and why the right investor might find you before you ever find them.</p>